23/12/2003
ReGen Therapeutics Plc (‘ReGen’ or ‘the Company’) announces that it has today placed with new and existing shareholders 4.67 million new ordinary shares (‘New Shares’) at 2p per share to raise £93,400 before expenses (‘Placing’).
Application has been made for the New Shares to be admitted to the Alternative Investment Market of the London Stock Exchange Plc and dealings are expected to commence at 8am on 23 December 2003.
Executive Chairman Percy Lomax commented ‘This small Placing has been done by the Company to allocate shares to a few private investors who had previously expressed an interest in investing in the Company.’
For further information please contact:
Andrew Marshall
Marshall Robinson Roe
Tel No 020 7960 6007